WESTFORD, Mass., April 18, 2016 /PRNewswire/ -- Cynosure,
Inc. (Nasdaq: CYNO), which designs, manufactures and markets
medical devices for aesthetic procedures and precision surgical
applications worldwide, today announced that the Company will
release its first-quarter 2016 financial results before the market
opens on Tuesday, April 26, 2016 and
host a conference call for investors and analysts that day at
9:00 a.m. ET.
On the call, Chairman and Chief Executive Officer Michael Davin and President and Chief Financial
Officer Timothy Baker will discuss
Cynosure's financial results, as well as the Company's business
outlook and strategy.
Those who wish to listen to the conference call webcast should
visit the "Investors" section of the Company's website at
www.cynosure.com. The live call also can be accessed by
dialing (877) 709-8155 or (201) 689-8881. If you are unable to
listen to the live call, the webcast will be archived on the
Company's website.
About Cynosure, Inc.
Cynosure develops,
manufactures, and markets aesthetic treatment systems that
enable plastic surgeons, dermatologists and other medical
practitioners to perform non-invasive and minimally invasive
procedures to remove hair, treat vascular and benign pigmented
lesions, remove multi-colored tattoos, revitalize the skin, reduce
fat through non-invasive and minimally invasive laser lipolysis,
reduce cellulite, clear nails infected by toe fungus, ablate sweat
glands and improve vaginal health. Cynosure also markets
radiofrequency energy sourced medical devices for precision
surgical applications such as facial plastic and general surgery,
gynecology, ear, nose, and throat procedures, ophthalmology, oral
and maxillofacial surgery, podiatry and proctology. Cynosure's
product portfolio is composed of a broad range of energy sources
including Alexandrite, diode, Nd:YAG, picosecond, pulse dye,
Q-switched lasers, intense pulsed light and radiofrequency
technology. Cynosure sells its products globally under the
Cynosure, Palomar, ConBio and Ellman brand names through a direct
sales force in the United States,
Canada, Mexico, France, Morocco, Germany, Spain, the United
Kingdom, Australia,
China, Japan and Korea, and through international
distributors in approximately 120 other countries. For
corporate or product information, visit Cynosure's website at
www.cynosure.com.
Contact
Scott
Solomon
Senior Vice President
Sharon Merrill Associates
617-542-5300
cyno@investorrelations.com
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/cynosure-to-host-first-quarter-2016-financial-results-conference-call-on-april-26-300252804.html
SOURCE Cynosure, Inc.